The combination of HUWE1 inhibitors with carfilzomib enhanced the antiproliferative effects of either agent alone, and combination index (CI) analysis demonstrated some synergistic anti-MM activity (Fig. 5a; Supplementary Fig. 6a). Here, HUWE1 is linked to Miyoshi myopathy.